Jonathan Kantor

ORCID: 0000-0002-3256-3014
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nonmelanoma Skin Cancer Studies
  • Cutaneous Melanoma Detection and Management
  • Wound Healing and Treatments
  • Body Contouring and Surgery
  • Medicine and Dermatology Studies History
  • Surgical Sutures and Adhesives
  • Skin Protection and Aging
  • Facial Rejuvenation and Surgery Techniques
  • Digital Imaging in Medicine
  • Diabetic Foot Ulcer Assessment and Management
  • Dermatology and Skin Diseases
  • Reconstructive Facial Surgery Techniques
  • Dermatologic Treatments and Research
  • Cutaneous lymphoproliferative disorders research
  • Pressure Ulcer Prevention and Management
  • Body Image and Dysmorphia Studies
  • Reconstructive Surgery and Microvascular Techniques
  • Nail Diseases and Treatments
  • Dupuytren's Contracture and Treatments
  • COVID-19 and Mental Health
  • Dermatological and COVID-19 studies
  • Vaccine Coverage and Hesitancy
  • Diagnosis and Treatment of Venous Diseases
  • Hair Growth and Disorders
  • Psoriasis: Treatment and Pathogenesis

Center for Global Health
2020-2025

Florida Center for Dermatology
2016-2025

University of Pennsylvania
2016-2025

University of Oxford
2023-2025

Miami Children's Hospital
2025

Science Oxford
2024

RELX Group (United States)
2020-2023

American Academy of Dermatology
2013-2022

Philadelphia University
2018-2021

Indra (Spain)
2021

OBJECTIVE—The goal of this study was to specifically estimate the effectiveness platelet releasate, a widely available treatment administered by proprietary group wound care centers (WCCs) for diabetic neuropathic foot ulceration. RESEARCH DESIGN AND METHODS—Treatment estimated in retrospective cohort controlling selection bias using logistic regression–derived propensity scores. RESULTS—Platelet releasate more effective than standard care. The relative risk heal after with compared at WCC...

10.2337/diacare.24.3.483 article EN Diabetes Care 2001-03-01

10.1046/j.1523-1747.2003.12540.x article EN publisher-specific-oa Journal of Investigative Dermatology 2003-11-01

Journal Article A multicentre study of percentage change in venous leg ulcer area as a prognostic index healing at 24 weeks Get access J. Kantor, Kantor Biostatistics and Epidemiology (Room 110), Blockley Hall, 423 Guardian Drive, University Pennsylvania School Medicine, Philadelphia, PA 19104, U.S.A. J.Kantor. E‐mail: jkantor@cceb.med.upenn.edu Search for other works by this author on: Oxford Academic Google Scholar D.J. Margolis U.S.A.Departments Dermatology 815) British Dermatology,...

10.1046/j.1365-2133.2000.03478.x article EN British Journal of Dermatology 2000-05-01

ATX-101, an injectable form of deoxycholic acid, causes adipocytolysis when injected subcutaneously into fat.We sought to evaluate the efficacy and safety ATX-101.In this phase III trial (REFINE-2), adults dissatisfied with their moderate or severe submental fat (SMF) were randomized ATX-101 placebo. Coprimary end points, evaluated at 12 weeks after last treatment, composite improvements 1 more grades 2 in SMF observed on both validated Clinician- Patient-Reported Rating Scales. Other points...

10.1016/j.jaad.2016.04.028 article EN cc-by-nc-nd Journal of the American Academy of Dermatology 2016-07-17

Nonpharmaceutical interventions (NPIs) represent the primary mitigation strategy for pandemic COVID-19. Despite this, many government agencies and members of general public may be resistant to NPI adoption. We sought understand attitudes beliefs regarding various NPIs self-reported adoption NPIs, explore associations between performance baseline characteristics respondents. performed a cross-sectional age-, sex-, race- stratified survey US population. Of 1,005 respondents, 37% (95% CI 34.0,...

10.3389/fmed.2020.00384 article EN cc-by Frontiers in Medicine 2020-07-03

<h3>Importance</h3> Until recently, no ideal valid, feasible, and reliable scar scale existed to effectively assess the quality of postoperative linear scars. The Scar Cosmesis Assessment Rating (SCAR) was developed validated as a tool scars in clinical research settings. <h3>Objective</h3> To reliability using photographs lieu live patient rating assessments, determine interrater intrarater SCAR scale. <h3>Design, Setting, Participants</h3> This study clinicians’ reliability, well...

10.1001/jamadermatol.2016.3757 article EN JAMA Dermatology 2016-11-02

Pandemic coronavirus disease 2019 (COVID-19) may lead to significant mental health stresses, potentially with modifiable risk factors. We performed an internet-based cross-sectional survey of age-, sex-, and race-stratified representative sample from the US general population. Degrees anxiety, depression, loneliness were assessed using 7-item Generalized Anxiety Disorder-7 scale (GAD-7), 9-item Patient Health Questionnaire, 8-item UCLA Loneliness Scale, respectively. Unadjusted multivariable...

10.3389/fpsyt.2020.569083 article EN cc-by Frontiers in Psychiatry 2020-12-09

To assess the association between planimetric wound area and simple measurements. ascertain applicability of planimetry-based research to clinical practice.A retrospective cohort study 260 consecutive patients followed up for at least 24 weeks.Outpatient dermatology department a major medical center.Wounds were measured using computer-based planimetry treated according standard protocol venous leg ulcers.Two hundred sixty with ulcers.Complete ulcer healing weeks.Using Pearson, Spearman,...

10.1001/archderm.134.12.1571 article EN Archives of Dermatology 1998-12-01

To determine the proportion of patients in a private dermatology practice whom melanoma was detected but not presenting complaint.Retrospective analytical case series.Private Florida, from July 2005 through October 2008. Patients with 126 melanomas, which 51 were invasive and 75 melanomas situ.Proportion as result patient complaint vs determined by dermatologist-conducted full-body skin examination (FBSE). As secondary analysis, we used logistic regression odds ratios (ORs) association to...

10.1001/archdermatol.2009.137 article EN Archives of Dermatology 2009-08-01

Objectives The COVID-19 pandemic has been associated with sleep quality impairment and psychological distress, the general public responded to quarantine requirements in a variety of ways. We aimed investigate whether is low during short-term (circuit break) restriction, respondents' overall attitudes using validated scale. Design Setting Online cross-sectional study England November 2020. Participants included 502 respondents over age 18. Measurements Sleep was assessed Pittsburgh Quality...

10.3389/fpubh.2022.819231 article EN cc-by Frontiers in Public Health 2022-07-15

This case study reports a 6-week-old female with PHACE syndrome and vestibular schwannoma, an exceedingly rare combination not previously documented in medical literature. syndrome, characterized by posterior fossa malformations, large facial hemangiomas, arterial anomalies, manifested the patient enlarging hemangioma obstructing her left eye. Imaging studies revealed cerebellar hypoplasia, absent right vertebral artery, A1 portion of anterior cerebral suspected acoustic neuroma...

10.7759/cureus.78946 article EN Cureus 2025-02-13

Next-generation vaccine delivery technologies may provide significant gains from both a technical and behavioral standpoint, but no scale has yet been developed to assess public attitudes novel technologies. We therefore performed cross-sectional validation study that included 1,001 demographically representative participants the UK US develop validate scale, Oxford Benchmark Scale for Rating Vaccine Technologies (OBSRVT). A sample of 500 was used perform exploratory factor analysis with...

10.1080/21645515.2025.2469994 article EN cc-by Human Vaccines & Immunotherapeutics 2025-03-03

Introduction Objective response rate (ORR), defined as the percentage of patients achieving a complete or partial to treatment, is critical endpoint in clinical trials assessing efficacy new therapies solid tumors, including BCC. We performed post-hoc analysis exploring ORR potential primary for future studies evaluating VP-315, an intratumorally injected, chemotherapeutic oncolytic peptide. To evaluate effect various VP-315 8 mg dosing regimens on antitumor subjects with Methods Eighty-two...

10.25251/skin.10.supp.565 article EN cc-by SKIN The Journal of Cutaneous Medicine 2025-03-17
Coming Soon ...